$1.09
-0.01-0.91%
At close: -
$1.09
0.000.00%
After Hours: Jan 17, 7:56 PM EDT
Comments
Loading...
Sangamo Therapeutics (NASDAQ:SGMO) Stock, Earnings Estimates, EPS, And Revenue
Sangamo Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 12
EPS
$0.040
Quarterly Revenue
$49.41M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$52.29M
Analyze the earnings history of Sangamo Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Sangamo Therapeutics (SGMO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $0.04 | $-0.03 | 233.3 % |
| Q2 | 2024-08-06 | $-0.18 | $-0.15 | -20.0 % |
| Q1 | 2024-05-09 | $-0.27 | $-0.21 | -28.6 % |
| Q4 | 2024-03-13 | $-0.34 | $-0.26 | -30.8 % |
Sangamo Therapeutics (SGMO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $49.41M | $17.94M | 175.4 % |
| Q2 | 2024-08-06 | $356.00K | $8.26M | -95.7 % |
| Q1 | 2024-05-09 | $481.00K | $6.65M | -92.8 % |
| Q4 | 2024-03-13 | $2.04M | $8.10M | -74.8 % |
FAQ
When is Sangamo Therapeutics (NASDAQ:SGMO) reporting earnings?
Sangamo Therapeutics (SGMO) is scheduled to report earnings on March 12, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Sangamo Therapeutics (NASDAQ:SGMO)?
The Actual EPS was $0.04, which beat the estimate of $-0.03.
What were Sangamo Therapeutics’s (NASDAQ:SGMO) revenues?
The Actual Revenue was $49.4M, which beat the estimate of $17.9M.
Browse earnings estimates, EPS, and revenue on all stocks.